You are here: Industry Insights > Diabetes

News List

FDA declines to approve Provention Bio’s teplizumab for diabetes pharmaceutical-technology
July 08, 2021
The US Food and Drug Administration (FDA) has declined to approve Provention Bio’s biologics licence application (BLA) for teplizumab in type 1 diabetes (T1D), an autoimmune disease.
Ildong Pharmaceutical starts Phase 1 study of new diabetes therapy in Germany prnasia
July 02, 2021
A Phase 1 study on new drug candidate IDG16177 of novel oral treatment for type 2 diabetes, which is being developed by Ildong Pharmaceutical, is initiated in Germany.
New Late-Breaking Data at The American Diabetes Association Show GlycoMark? May Be an Effective Test for COVID-19 Severity prnasia
June 29, 2021
Precision Diabetes, Inc. and Patia announced results from a study showing that the GlycoMark blood test may be an effective marker of stress hyperglycemia and severity in COVID-19 patients, particularly in patients without diabetes.
Lilly’s tirzepatide beats Ozempic in head-to-head type 2 diabetes trial pharmatimes
June 29, 2021
Eli Lilly has announced that its investigational GIP and GLP-1 inhibitor tirzepatide showed superiority over Novo Nordisk’s Ozempic in a Phase III trial.
Four in 10 Diabetes Patients Have Kidney Disease drugs
June 24, 2021
More than four in 10 patients with diabetes have diabetic kidney disease (DKD), according to a study published online June 14 in BMJ Open Diabetes Research & Care.
America Is Losing the War Against Diabetes drugs
June 11, 2021
After years of improvement, Americans with diabetes may be losing some ground in controlling the condition, a new government-funded study shows.
Vaccine slows loss of insulin production in type 1 diabetes genetic subgroup europeanpharmaceuticalreview
June 03, 2021
In a Phase II trial, injecting GAD-alum into the lymph nodes of newly diagnosed type 1 diabetes patients with a genetic variant slowed insulin production degradation.
Daewoong Pharmaceutical Publishes Results of First Clinical Study of SGLT-2 Inhibitor 'Enavogliflozin' for Canine Diabetes prnasia
June 02, 2021
Daewoong Pharmaceutical (CEO Sengho Jeon) announced that the results of an investigator-initiated clinical study on the effect of Enavogliflozin, originally developed as Type II Diabetes Treatment for humans, on treating canine diabetes were published ...
Veeva Commercial Summit to Spotlight Digital Innovation at Leading Life Sciences Companies prnewswire
June 02, 2021
Veeva Systems today announced that leaders from Boehringer Ingelheim, GSK, and UCB will be among the featured keynote speakers at the 2021 Veeva Commercial & Medical North America Summit Connect on June 10, 2021.
Social & Health Research Center and Quest Diagnostics Team Up to Address Childhood Hunger and Obesity Exacerbated by COVID-19 in Underserved Communities prnewswire
May 25, 2021
Childhood obesity has disproportionately affected Hispanic and Black communities as a result of negative social determinants of health for years.